Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

Clinical trial NCT00624338 · COMPLETED

Trial details

NCT number: NCT00624338
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic

Start date: 2008-01-01
Primary completion: 2012-04-01
Enrollment: 461

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.